Andrea V. Lopez

CD40 Ligand-Modified Chimeric Antigen Receptor T Cells Enhance Antitumor Function by Eliciting an Endogenous Antitumor Response

Nicholas F. Kuhn, Terence J. Purdon, Dayenne G. van Leeuwen et al. · Cancer Cell · 2019 · 230 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, Medicine +6

Defining an Optimal Dual-Targeted CAR T-cell Therapy Approach Simultaneously Targeting BCMA and GPRC5D to Prevent BCMA Escape–Driven Relapse in Multiple Myeloma

Carlos Fernández de Larrea, Andrea V. Lopez, Khong Y. Ng et al. · Blood Cancer Discovery · 2020 · 205 citations · Full text

IL-18–secreting CAR T cells targeting DLL3 are highly effective in small cell lung cancer models

Janneke E. Jaspers, Jonathan F. Khan, William D. Godfrey et al. · Journal of Clinical Investigation · 2023 · 144 citations · Full text

Cytokine IL-36γ improves CAR T-cell functionality and induces endogenous antitumor response

Xinghuo Li, Anthony F. Daniyan, Andrea V. Lopez et al. · Leukemia · 2020 · 60 citations · Full text

Inflammation, Cytokine, Cytokine Il-36γ +11

CD103+ cDC1 and endogenous CD8+ T cells are necessary for improved CD40L-overexpressing CAR T cell antitumor function

Nicholas F. Kuhn, Andrea V. Lopez, Xinghuo Li et al. · Nature Communications · 2020 · 46 citations · Full text